Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

TY - JOUR

T1 - Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic

T2 - From the North American Society Leadership

AU - Wood, David A.

AU - Mahmud, Ehtisham

AU - Thourani, Vinod H.

AU - Sathananthan, Janarthanan

AU - Virani, Alice

AU - Poppas, Athena

AU - Harrington, Robert A.

AU - Dearani, Joseph A.

AU - Swaminathan, Madhav

AU - Russo, Andrea M.

AU - Blankstein, Ron

AU - Dorbala, Sharmila

AU - Carr, James

AU - Virani, Sean

AU - Gin, Kenneth

AU - Packard, Alan

AU - Dilsizian, Vasken

AU - Légaré, Jean François

AU - Leipsic, Jonathon

AU - Webb, John G.

AU - Krahn, Andrew D.

N1 - Funding Information: Dr Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr Harrington has served on an Advisory Committee for Element Science. Dr Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr Sean Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the The Annals author instructions page. Funding Information: Dr Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr Harrington has served on an Advisory Committee for Element Science. Dr Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr Sean Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the The Annals author instructions page .

PY - 2020/8

Y1 - 2020/8

UR - http://www.scopus.com/inward/record.url?scp=85087868696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087868696&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2020.04.017

DO - 10.1016/j.athoracsur.2020.04.017

M3 - Article

C2 - 32380058

AN - SCOPUS:85087868696

SN - 0003-4975

VL - 110

SP - 733

EP - 740

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 2

ER -